$EQBK

Equity Bancshares, Inc. Stock 12‑Month Price Target Cut to $54.43, Implies 17% Upside

Equity Bancshares' average stock price target was reduced from $55.29 to $54.43 by 7 analysts, with a range of $50 to $61. This implies a 17% upside from the Oct. 14 closing price. The consensus rating remains 'Buy' with 2 Buys, 5 Holds, and 0 Sells.

Original reporting
Published Oct 15, 2026, 10:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 10:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Equity Bancshares, Inc. Stock 12‑Month Price Target Cut to $54.43, Implies 17% Upside — source image
Decision brief

The 30-second read

$EQBKNeutralLow
01

Why it matters

For trading, the key actionable element is the direction of the consensus PT (down) and whether the rating changed (it did not).

02

Market read

This is a routine analyst-target revision rather than a new fundamental event, so it is more likely to cause incremental sentiment drift than a major repricing.

03

What to watch

The article does not disclose the underlying thesis for the PT change, so traders may overreact to the headline PT level without knowing whether assumptions improved or worsened.

Relevance 4/10Novelty 4/10Timing: as soon as the analyst-target update is digested by the market

Background

The piece summarizes a consensus analyst price-target update for Equity Bancshares based on estimates from seven analysts.

Company-level read

Ticker impact

$EQBKNeutralMedium confidence
Context

Equity Bancshares’ average analyst price target was cut from $55.29 to $54.43, with forecasts spanning $50 to $61 and consensus still “Buy.”

Expected impact

Likely modest pressure as traders price in the lower consensus target, partially offset by the continued Buy rating.

Evidence & confidence

The article reports a specific consensus PT cut and the distribution of targets, but provides no new fundamental catalyst beyond analyst estimate revisions.

Market effects

Minimal, since this is a single-bank analyst target adjustment with no sector-wide policy or regulatory change.

Limited, as the update is company-specific and not tied to a broader regional banking shock.

Low, no cross-border deal, macro shock, or global regulatory action is mentioned.

Counterpoint

A PT cut can reflect valuation normalization rather than deteriorating fundamentals, especially with consensus remaining “Buy.”

Key entities

  • Equity Bancshares, Inc.

    US-listed bank whose consensus analyst price target was reduced to $54.43 while maintaining a “Buy” consensus.

Related articles

$EQBKMed

Equity Bancshares (EQBK) Q3 2026 Earnings Call Transcript

Equity Bancshares (EQBK) reported Q3 2026 earnings, highlighting organic growth with loans up $39M to $5.44B and deposits down $136M to $6.17B. The company announced a merger with Lincoln Bancorp, adding 16 branches in Iowa. Net income was $26.8M, or $1.29 per diluted share. The company expects margin to return to 4.25-4.35% in Q4, excluding the merger.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

$EQBKMed

Equity Bancshares Q3 2026 slides: EPS beats amid margin pressure

Equity Bancshares (EQBK) reported Q3 2026 earnings of $1.40 per share, beating estimates, though revenue fell slightly short. The stock rose 0.99% to $47.03. The bank faces margin pressure but continues growth through acquisitions, including the pending Lincoln Savings Bank deal. Asset quality showed some deterioration, with nonperforming assets rising to 0.99%. The company is investing in AI to improve efficiency.

$EQBKMed

Equity Bancshares (EQBK) Posts Solid Net Interest Income Despite

Equity Bancshares (EQBK) reported Q2 2026 net interest income of $72.8M, down slightly from the prior quarter but up 16.6% year-over-year. The company's GF Value™ suggests it is modestly undervalued with a 15.2% margin of safety. EQBK has a GF Score™ of 81/100, indicating strong fundamentals in valuation and momentum, but weaker financial strength. Insiders and gurus have shown net selling activity. The stock trades at $46.57 with a trailing P/E of 27.97x and a forward P/E of 8.55x.